Torres-Espíndola Luz-María (Luz María Torres-Espíndola, Luz Maria Torres Espíndola)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Oxide Nanoparticles

Top Venues

Infection and drug resistance

Molecular biology reports

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Hugo Ahumada Topete, Kevin Jesus de Dios Sanchez, Gustavo Alejandro Casas Aparicio, Graciela Hernandez Silva, Cesar Emmanuel Lopez Vejar, Torres-Espíndola Luz-María, Arnoldo Aquino-Galvez, Odalis Rodriguez Ganen, Manuel de Jesus Castillejos Lopez
Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature. Infection and drug resistance 16 (2023)
Victor Hugo Ahumada Topete, Kevin Jesus de Dios Sanchez, Gustavo Alejandro Casas Aparicio, Graciela Hernandez Silva, Cesar Emmanuel Lopez Vejar, Torres-Espíndola Luz-María, Arnoldo Aquino-Galvez, Odalis Rodriguez Ganen, Manuel de Jesus Castillejos Lopez
Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature. Infection and drug resistance 16 (2023)
Carmen Flores-Pérez, Manuel de Jesús Castillejos-López, Juan Luis Chávez-Pacheco, Víctor Manuel Dávila-Borja, Janett Flores-Pérez, Patricia Zárate-Castañón, Mario Acosta-Bastidas, Jonathan Cruz-Escobar, Torres-Espíndola Luz-María
The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients. Journal of clinical pharmacy and therapeutics 46 (3) (2021)
Pérez-De Marcos Juan-Carlos, Pérez-Pineda Perla-Lidia, Méndez-Morales Stephanie-Talia, Arellano-Mendoza Mónica-Griselda, Torres-Espíndola Luz-María
ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine. Molecular biology reports 48 (2) (2021)